RDGL OTC
Vivos Inc.
1W: -0.2%
1M: -15.3%
3M: -46.6%
YTD: -33.7%
1Y: -49.0%
3Y: -31.7%
5Y: -61.8%
$0.05
-0.00 (-8.05%)
Weekly Expected Move ±8.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$22.6M
52W Range0.04-0.1244
Volume231,317
Avg Volume1,305,483
Beta-0.71
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael K. Korenko
Employees1
SectorHealthcare
IndustryMedical - Devices
IPO Date1998-09-02
Websiteradiogel.com
1030 N Center Parkway
Kennewick, WA 99352
US
Kennewick, WA 99352
US
509 736 4000
About Vivos Inc.
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Latest News
Vivos Inc. (RDGL) reports Q2 loss, cash burn and key FDA trial progress - stocktitan.net
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
Contrasting Advanced Medical Isotope (OTCMKTS:RDGL) and Hercules Capital (NYSE:HTGC)
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Weeks Brad Allan | P-Purchase | 25,550 | $0.05 | 2026-09-16 |
| Korenko Michael K | P-Purchase | 150,000 | $0.05 | 2026-08-10 |
| Weeks Brad Allan | P-Purchase | 50,000 | $0.05 | 2026-08-10 |
| Weeks Brad Allan | P-Purchase | 32,000 | $0.05 | 2026-07-22 |
| Weeks Brad Allan | P-Purchase | 60,000 | $0.05 | 2026-07-21 |